CORTERIA PHARMACEUTICALS
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
CORTERIA PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2021-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.corteriapharma.com
Status:
Active
Total Funding:
12 M EUR
Technology used in webpage:
Microsoft Exchange Online
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Omnes Capital
Omnes Capital investment in Seed Round - Corteria Pharmaceuticals
V-Bio Ventures
V-Bio Ventures investment in Seed Round - Corteria Pharmaceuticals
Invivo Capital Partners
Invivo Capital Partners investment in Seed Round - Corteria Pharmaceuticals
Kurma Partners
Kurma Partners investment in Seed Round - Corteria Pharmaceuticals
Official Site Inspections
http://www.corteriapharma.com
- Host name: cluster027.hosting.ovh.net
- IP address: 54.36.91.62
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Corteria Pharmaceuticals"
Home page - Corteria
About us FOCUSED ON THE DEVELOPMENT OF TRANSFORMATIVE THERAPIES FOR …See details»
Leadership - Corteria
Regis brings more than 30 years of experience in the areas of finance, structuring and …See details»
Board of directors - Corteria - corteriapharma.com
Andreas was part of several successful product developments and market introductions. Before the integration of Genentech (now a wholly owned member of The Roche Group), Andreas was Global Head of Clinical Research and …See details»
Corteria Pharmaceuticals - Crunchbase Company Profile & Funding
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused …See details»
Corteria Pharmaceuticals - VentureRadar
"Founded in 2021, Corteria Pharmaceuticals is a privately held company developing first-in …See details»
Corteria Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The …
View Corteria Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Corteria Pharmaceuticals - EU-Startups
Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.See details»
Corteria Pharmaceuticals - LinkedIn
Corteria Pharmaceuticals | 1,836 followers on LinkedIn. Interceptive therapies for the treatment of heart failure subpopulations | Development of transformative therapies for the treatment of ...See details»
Corteria Pharmaceuticals Announces a €65M ($71M) Financing to …
Paris (France), 07 September 2023 – Corteria Pharmaceuticals (“Corteria”), a …See details»
Corteria Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
More information available at: www.corteriapharma.com [1] Applying a 1.0886 EUR/USD …See details»
Corteria Pharmaceuticals Company Profile: Overview and Full …
Corteriapharma.com Overview: Corteria Pharmaceuticals Corteria Pharmaceuticals, located in …See details»
Corteria Pharmaceuticals - Overview, News & Similar ... - ZoomInfo
View Corteria Pharmaceuticals (corteriapharma.com) location in Ile-de-France, France , revenue, industry and description. Find related and similar companies as well as employees by title and much more. Products. Contact & Company Search …See details»
Corteria Pharmaceuticals strengthens its Executive Leadership …
Oct 21, 2022 Corteria Pharmaceuticals, a biotechnology company developing innovative …See details»
V-Bio Ventures portfolio company Corteria Pharmaceuticals raises …
Ghent, Belgium, 7 September 2023 – Corteria Pharmaceuticals, a V-Bio Ventures portfolio …See details»
Corteria Pharmaceuticals Announces a 65M ($71M Financing to …
More information available at: www.corteriapharma.com Investors/media contacts Stéphane …See details»
Corteria Pharmaceuticals Company Information - Funding, …
Https://corteriapharma.com. Interceptive therapies for heart failure subpopulations. GET THE …See details»
Corteria Pharmaceuticals Announces Closing of €12M Seed …
Www.corteriapharma.com PRESS RELEASE Corteria Pharmaceuticals Announces Closing of …See details»
Corteria Pharmaceuticals lève 65 millions d’euros pour poursuivre …
Paris, France, le 7 septembre 2023 – Corteria Pharmaceuticals (‘Corteria’), société …See details»
Corteria Pharmaceuticals Announces a €65M Financing to Advance ...
Paris (France), 07 September 2023 – Corteria Pharmaceuticals (“Corteria”), a …See details»
Corteria Pharmaceuticals Announces Closing of €12M Seed …
Paris, France, December 09th, 2021 – Corteria Pharmaceuticals, a French biotechnology …See details»